Testing a Ring-Type Wearable Blood Pressure Monitor Against a Standard Method
Tests a ring device for blood pressure in adults with suspected high or low pressure.
Plain-language title generated from the registry record
Registry title: Validation Study of CART BP as a Wearable Cuffless Blood Pressure Monitor
Key facts
- Where
- Seoul, South KoreaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
Source: NCT06513975, who can take part
Where in South Korea
- Samsung Medical CenterSeoul, South KoreaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Sky Labs
- Trial code
- NCT06513975
- Record updated
- 15 June 2025
- Original description
This study aims to evaluate the accuracy of the CART BP, a medically approved ring-type blood pressure monitor, in comparison to the traditional auscultatory method using a dual-head stethoscope. The comparison is conducted in accordance with the 2023 European Society of Hypertension (ESH) Recommendations, focusing on patients with suspected hypertension or hypotension. The evaluation includes accuracy measurements across various postures and during different exercise periods.Read full original descriptionShow less
Validation Study of CART BP as a Wearable Cuffless Blood Pressure Monitor: Evaluation of Blood Pressure Measurement by Height and Physical Activity
This study aims to evaluate the accuracy of the CART BP, a medically approved ring-type blood pressure monitor, in comparison to the traditional auscultatory method using a dual-head stethoscope. The comparison is conducted in accordance with the 2023 European Society of Hypertension (ESH) Recommendations, focusing on patients with suspected hypertension or hypotension. The evaluation includes accuracy measurements across various postures and during different exercise periods.
Inclusion: Subjects aged 18 years or older but younger than 80 years; Individuals who voluntarily decide to participate in this clinical trial and provide written consent to the information and consent form; Individuals willing to comply with the clinical trial protocol.
Exclusion: Patients or volunteers with underlying heart diseases: those with a history of hospitalization for heart failure, valvular disease, or myocardial infarction; Patients or volunteers with end-stage renal disease (undergoing dialysis); Subjects who do not consent to the study; Obese individuals with a Body Mass Index (BMI) of 30 or higher (concerns about measurement errors as the standard 24-hour ambulatory blood pressure monitor cuff may not fit the arm properly); Patients or volunteers who are pregnant; Patients or volunteers diagnosed with atrial fibrillation on a 12-lead electrocardiogram (ECG) within the past 6 months; Patients or volunteers unable to perform repeated exercises required for the study; Patients or volunteers with a systolic blood pressure (SBP) exceeding 160 millimeters of mercury (mmHg); Patients or volunteers with a systolic blood pressure (SBP) exceeding 160 millimeters of mercury (mmHg) and/or a diastolic blood pressure (DBP) exceeding 100 millimeters of mercury (mmHg) (for exercise tests).